Literature DB >> 15710237

Regulation of serine racemase activity by amino acids.

David S Dunlop1, Amos Neidle.   

Abstract

The effects of various amino acids on the activity of serine racemase, purified from mouse brain, were examined. Those acting as inhibitors included compounds with electron withdrawing groups on the beta-carbon of alanine (beta-halo-alanines and L-serine-O-sulfate), which can act as enzyme-activated inhibitors, and compounds containing beta-SH groups (cysteine and homocysteine) which react with enzyme-bound pyridoxal phosphate to form thiazolidine derivatives. Glycine and a series of metabolites related to L-aspartic acid (L-aspartic acid, L-asparagine, and oxaloacetic acid) were also found to be competitive inhibitors of the racemase. The Ki values for glycine and aspartic acid inhibition were 0.15 and 1.9 mM, respectively, indicating that alterations in the concentrations of these amino acids might play a role in the regulation of D-serine synthesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710237     DOI: 10.1016/j.molbrainres.2004.10.027

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  15 in total

1.  Capillary electrophoresis-laser-induced fluorescence (CE-LIF) assay for measurement of intracellular D-serine and serine racemase activity.

Authors:  Nagendra S Singh; Rajib K Paul; Megan Sichler; Ruin Moaddel; Michel Bernier; Irving W Wainer
Journal:  Anal Biochem       Date:  2011-10-10       Impact factor: 3.365

Review 2.  Metabolism of the neuromodulator D-serine.

Authors:  Loredano Pollegioni; Silvia Sacchi
Journal:  Cell Mol Life Sci       Date:  2010-03-02       Impact factor: 9.261

3.  D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis.

Authors:  Jumpei Sasabe; Tomohiro Chiba; Marina Yamada; Koichi Okamoto; Ikuo Nishimoto; Masaaki Matsuoka; Sadakazu Aiso
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

4.  The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle.

Authors:  Samah Neame; Hazem Safory; Inna Radzishevsky; Ayelet Touitou; Francesco Marchesani; Marialaura Marchetti; Shai Kellner; Shai Berlin; Veronika N Foltyn; Simone Engelender; Jean-Marie Billard; Herman Wolosker
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

5.  Glycine and D: -serine, but not D: -cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801.

Authors:  Nobuhisa Kanahara; Eiji Shimizu; Shintaro Ohgake; Yuko Fujita; Mami Kohno; Tasuku Hashimoto; Daisuke Matsuzawa; Yukihiko Shirayama; Kenji Hashimoto; Masaomi Iyo
Journal:  Psychopharmacology (Berl)       Date:  2008-04-24       Impact factor: 4.530

6.  Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model.

Authors:  Viviane Labrie; Ryutaro Fukumura; Anjali Rastogi; Laura J Fick; Wei Wang; Paul C Boutros; James L Kennedy; Mawahib O Semeralul; Frankie H Lee; Glen B Baker; Denise D Belsham; Steven W Barger; Yoichi Gondo; Albert H C Wong; John C Roder
Journal:  Hum Mol Genet       Date:  2009-05-30       Impact factor: 6.150

7.  Roles of quaternary structure and cysteine residues in the activity of human serine racemase.

Authors:  Wei Wang; Steven W Barger
Journal:  BMC Biochem       Date:  2011-12-08       Impact factor: 4.059

Review 8.  D-serine signalling as a prominent determinant of neuronal-glial dialogue in the healthy and diseased brain.

Authors:  J-M Billard
Journal:  J Cell Mol Med       Date:  2008-03-20       Impact factor: 5.310

Review 9.  Serine racemase: a key player in apoptosis and necrosis.

Authors:  Nadia Canu; Maria Teresa Ciotti; Loredano Pollegioni
Journal:  Front Synaptic Neurosci       Date:  2014-04-21

10.  A Novel Bifunctional Amino Acid Racemase With Multiple Substrate Specificity, MalY From Lactobacillus sakei LT-13: Genome-Based Identification and Enzymological Characterization.

Authors:  Shiro Kato; Tadao Oikawa
Journal:  Front Microbiol       Date:  2018-03-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.